Diffusion Pharmaceuticals Inc.

Common Stock SEC Reporting - Current
OTCQX U.S. OTCQX Advisor: Oppenheimer Wolff & Donnelly LLP
Verified Company Profile 10/06/2016
Contact Info
  • 2020 Avon Court
  • Suite 4
  • Charlottesville, VA 22902

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2016 10-Q
CIK 0001053691
Fiscal Year End 12/31
OTC Marketplace OTCQX U.S.
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o Jul 02, 2015
Incorporated In: DE, USA
Year of Inc. 2001
Employees 10 a/o Jan 27, 2016
Company Officers/Contacts
David G. Kalergis CEO
Ben L. Shealy Senior VP, Treasurer
David R. Jones, M.D. Chief Med. Officer
John L. Gainer, Ph.D Chief Scientific Officer
Thomas E. Byrne General Counsel
Stephanie Carrington IR
Company Directors
David G. Kalergis Chairman
Alan G. Levin Chairman
Robert W. Adams Chairman
Isaac Blech
Mark T. Giles
John L. Gainer, Ph.D
Company Notes
  • Formerly=RestorGenex Corporation until 1-2016
  • Formerly=Stratus Media Group, Inc. until 3-2014
  • Formerly=Feris International, Inc. until 7-2008
  • Formerly=Titan Motorcycle Company of America until 8-05
  • Formerly=Mojave Financial Services, Inc. until 6-96
Service Providers
OTCQX Advisor
Oppenheimer Wolff & Donnelly LLP
222 South Ninth Street
Suite 2000
Minneapolis, MN, 55402

Accounting/Auditing Firm
1676 International Drive
McLean, VA, 22101
United States

Legal Counsel
Dechert LLP
1905 Avenue of the Americas
New York, NY, 10036-6797
United States

Investor Relations Firm
ICR (New York Office)
825 Third Ave.
31st Floor
New York, NY, 10022
United States

DFFN Security Details
Share Structure
Market Value1 $62,072,094 a/o Oct 21, 2016
Authorized Shares 1,000,000,000 a/o Aug 16, 2016
Outstanding Shares 10,345,349 a/o Aug 16, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value Not Available
Shareholders of Record 1,140 a/o Mar 25, 2016
Short Selling Data
Short Interest 0 (-100%)
Aug 31, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security